LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
MCF7	Sorafenib	1.11	uM	LJP6	72	hr	1235	3680	4056	0.9076	0.8897
MCF7	Sorafenib	10	uM	LJP6	72	hr	1235	1645	4056	0.4061	0.1821
MCF7	Sorafenib	0.12	uM	LJP6	72	hr	1235	3561	4056	0.8777	0.8530
MCF7	Sorafenib	0.37	uM	LJP6	72	hr	1235	3908	4056	0.9638	0.9574
MCF7	Sorafenib	3.33	uM	LJP6	72	hr	1235	3446	4056	0.8503	0.8195
MCF7	AT-7519	0.04	uM	LJP6	72	hr	1235	3560	4056	0.8771	0.8520
MCF7	AT-7519	0.12	uM	LJP6	72	hr	1235	1396	4056	0.3443	0.0741
MCF7	AT-7519	0.37	uM	LJP6	72	hr	1235	834	4056	0.2059	-0.2046
MCF7	AT-7519	1.11	uM	LJP6	72	hr	1235	861	4056	0.2124	-0.1898
MCF7	AT-7519	3.33	uM	LJP6	72	hr	1235	893	4056	0.2202	-0.1723
MCF7	AT-7519	10	uM	LJP6	72	hr	1235	735	4056	0.1810	-0.2625
MCF7	AZD7762	0.04	uM	LJP6	72	hr	1235	1904	4056	0.4696	0.2871
MCF7	AZD7762	0.12	uM	LJP6	72	hr	1235	1706	4056	0.4209	0.2074
MCF7	AZD7762	0.37	uM	LJP6	72	hr	1235	1544	4056	0.3810	0.1390
MCF7	AZD7762	1.11	uM	LJP6	72	hr	1235	1310	4056	0.3230	0.0347
MCF7	AZD7762	3.33	uM	LJP6	72	hr	1235	1057	4056	0.2607	-0.0870
MCF7	AZD7762	10	uM	LJP6	72	hr	1235	765	4056	0.1887	-0.2437
MCF7	AZD8055	0.04	uM	LJP6	72	hr	1235	1307	4056	0.3227	0.0327
MCF7	AZD8055	0.12	uM	LJP6	72	hr	1235	1319	4056	0.3253	0.0390
MCF7	AZD8055	0.37	uM	LJP6	72	hr	1235	1289	4056	0.3181	0.0251
MCF7	AZD8055	1.11	uM	LJP6	72	hr	1235	1291	4056	0.3187	0.0263
MCF7	AZD8055	3.33	uM	LJP6	72	hr	1235	1242	4056	0.3066	0.0029
MCF7	AZD8055	10	uM	LJP6	72	hr	1235	1116	4056	0.2755	-0.0574
MCF7	Sorafenib	0.04	uM	LJP6	72	hr	1235	3940	4056	0.9719	0.9672
MCF7	Alvocidib	0.04	uM	LJP6	72	hr	1235	1126	4056	0.2776	-0.0528

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)